Volume 5 Issue 1 - International Pharmaceutical Industry

Current Edition

V5 I1 Special Feature

Fifteen Years of Cardiac Safety: History, State-of-the- Science Research, and Glimpses into the Future

The field of cardiac safety employs clinical, statistical, and regulatory sciences during the preclinical and clinical development program of a noncardiac drug to pr...

11 April 2013 V5 I1 Special Feature | Volume 5 Issue 1

Continue Reading →

V5 I1 Packaging

Counterfeit medicines: a real danger to patients

Counterfeit medicine has been a subject of much concern for as long as the health and pharmaceutical sector has been established. Counterfeit drugs are a social prob...

11 April 2013 V5 I1 Packaging | Volume 5 Issue 1

Continue Reading →

V5 I1 Packaging

Collaborative Development: Finding Solutions for the Packaging Challenges of Modern Injectable Biologics

For the past 20 years, biotechnology medicines have aided those suffering from chronic conditions, including cancer, diabetes, and auto-immune diseases such as multi...

11 April 2013 V5 I1 Packaging | Volume 5 Issue 1

Continue Reading →

V5 I1 Manufacturing

Pure and Safe

Sterile services departments must ensure the consistent supply of sterilised tools and equipment throughout the hospital, and failure or delay can be distressing or ...

11 April 2013 V5 I1 Manufacturing | Volume 5 Issue 1

Continue Reading →

V5 I1 Manufacturing

Hands-on Lean Plus

Socio-economic pressure as well as increasingly strong competition have clearly made the entire healthcare industry focus a lot of attention on reducing costs. Not s...

11 April 2013 V5 I1 Manufacturing | Volume 5 Issue 1

Continue Reading →

V5 I1 Manufacturing

The Insulin Peptide Family

Insulin is only one member of a family of peptide hormones and growth factors that comprises 10 members in humans: insulin, insulin-like growth factors I and II and ...

11 April 2013 V5 I1 Manufacturing | Volume 5 Issue 1

Continue Reading →

V5 I1 Labs & Logistics

Optimised Connectivity is Fundamental to Integrity & Safety of Hygienic Processing

Every product for consumption, ingestion, injection, or cosmetic use must be safe for use and be in perfect condition when used. Micro- organisms, toxic substances a...

11 April 2013 V5 I1 Labs & Logistics | Volume 5 Issue 1

Continue Reading →

V5 I1 Clinical / Medical Research

Patient Recruitment: The Most Recognised Silent Driver of Clinical Development Costs.

Patient recruitment challenges the drug development process for a number of reasons. Elio Evangelista at Cutting Edge Information discusses why the increased demand ...

11 April 2013 V5 I1 Clinical / Medical Research | Volume 5 Issue 1

Continue Reading →

V5 I1 Clinical / Medical Research

Personalised Medicine Inventions – Is Patent Protection Possible?

Personalised Medicine Inventions – Is Patent Protection Possible? A recent decision from the US Supreme Court now questions whether patent protection for personalis...

11 April 2013 V5 I1 Clinical / Medical Research | Volume 5 Issue 1

Continue Reading →

V5 I1 Clinical / Medical Research

Biobank Management Systems

Biobanks are increasingly playing an important role in biotechnology, pharmaceutical and medical research. John Boother at Autoscribe Ltd looks into why the ability ...

11 April 2013 V5 I1 Clinical / Medical Research | Volume 5 Issue 1

Continue Reading →